Your Health, We Care
Deucravacitinib is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
Limitations of Use:
Deucravacitinib is not recommended for use in combination with other potent immunosuppressants.
from FDA，2022.09
Scan code
Whatsapp
LuciusVersionofDeucravacitinib:DosageandAdministration,Indications,PrecautionsIndicationsDeucravacit···【more】
Recommended：522025-18-12
Deucravacitinib is suitable for treating plaque psoriasis.【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：17
LuciusVersionofDeucravacitinib:DosageandAdministration,Indications,PrecautionsIndicationsDeucravacitinib is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adul···【more】
Article source：Lucius LaosRelease date：2025-12-18Recommended：52
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
